We are live on ! Find out more
EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

51 hedge funds and large institutions have $70.4M invested in Eiger BioPharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

60% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 10

17% more capital invested

Capital invested by funds: $60.4M → $70.4M (+$10M)

9% more funds holding

Funds holding: 47 → 51 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
51
Holders Change
+4
Holders Change %
+8.51%
% of All Funds
1.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
16
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
+$385K
2
PA
Perceptive Advisors
New York
+$339K
3
BFA
BlackRock Fund Advisors
California
+$246K
4
Deutsche Bank
Deutsche Bank
Germany
+$162K
5
SFM
Sphera Funds Management
Israel
+$143K

Top Sellers

Rank Fund Capital Flow
1
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$1.46M
2
DCM
DAFNA Capital Management
California
-$608K
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$211K
4
AIM
Acrospire Investment Management
Illinois
-$67K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$8.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$100K -$2.56K -7 -2%
TA
27
Teachers Advisors
New York
$64K – – –
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$63K – – –
Russell Investments Group
29
Russell Investments Group
United Kingdom
$60K +$67K +183 New
JP Morgan Chase
30
JP Morgan Chase
New York
$44K +$46.2K +126 New
BG
31
Bellevue Group
Switzerland
$39K – – –
Wells Fargo
32
Wells Fargo
California
$35K -$366 -1 -1%
BA
33
BlackRock Advisors
Delaware
$29K -$5.86K -16 -16%
NFA
34
Nationwide Fund Advisors
Ohio
$24K – – –
AIG
35
American International Group
New York
$23K -$366 -1 -1%
CG
36
Cutler Group
California
$13K – – –
SO
37
STRS Ohio
Ohio
$13K – – –
UBS Group
38
UBS Group
Switzerland
$10K +$1.47K +4 +17%
Legal & General Group
39
Legal & General Group
United Kingdom
$10K +$11.4K +31 New
LTFS
40
Ladenburg Thalmann Financial Services
Florida
$8K – – –
Bank of America
41
Bank of America
North Carolina
$7K +$1.83K +5 +36%
MAM
42
Meeder Asset Management
Ohio
$7K +$6.96K +19 New
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K – – –
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$4K +$4.03K +11 New
QCG
45
Quadrant Capital Group
Ohio
$4K +$5.13K +14 New
BlackRock
46
BlackRock
New York
$2K – – –
MFS
47
MSI Financial Services
Massachusetts
$2K – – –
Citigroup
48
Citigroup
New York
$2K +$366 +1 +25%
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$1K +$1.1K +3 New
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$664 -$2.56K -7 -78%
1
2
3

EIGR Hedge Fund Activity: Q4 2016 in Review

51 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Eiger BioPharmaceuticals, Inc. (EIGR) for Q4 2016, worth a combined $70.4M — up 17% from $60.4M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new EIGR positions and 4 closed out — a net gain of 5 holders — while 16 added to existing stakes and 10 trimmed.

The largest buyer was Monashee Investment Management, opening a new position worth an estimated $385K. The largest seller was Board of Trustees of The Leland Stanford Junior University, exiting entirely with an estimated $1.46M sold.

  • 51 institutional investors held Eiger BioPharmaceuticals, Inc. (EIGR) as of Q4 2016, up from 47 in Q3 2016.
  • Funds reported $70.4M of Eiger BioPharmaceuticals, Inc. stock for Q4 2016, up 17% quarter-over-quarter.
  • 9 funds opened new Eiger BioPharmaceuticals, Inc. positions in Q4 2016 and 4 closed out, a net change of +5 holders.
  • The largest Eiger BioPharmaceuticals, Inc. buyer in Q4 2016 was Monashee Investment Management, an estimated $385K added.
  • The largest Eiger BioPharmaceuticals, Inc. seller in Q4 2016 was Board of Trustees of The Leland Stanford Junior University, an estimated $1.46M sold.

Based on aggregated 13F filings for Q4 2016.